Published in Br J Cancer on July 08, 2008
Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339. J Biol Inorg Chem (2010) 0.96
Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade. Transl Oncol (2012) 0.89
Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. Br J Cancer (2012) 0.82
Inhibin/activin expression in human and rodent liver: subunits α and βB as new players in human hepatocellular carcinoma? Br J Cancer (2011) 0.77
Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis. Oncotarget (2017) 0.76
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis. Mod Pathol (2016) 0.75
Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib. Oncotarget (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Hepatocellular carcinoma. Lancet (2003) 22.54
Liver fibrosis. J Clin Invest (2005) 17.27
Stromal fibroblasts in cancer initiation and progression. Nature (2004) 11.69
Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57
Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer (2006) 10.05
Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer (2006) 8.59
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut (2005) 5.39
Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Nat Med (1996) 5.09
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res (1997) 4.22
The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer (2007) 4.01
Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol (1990) 2.36
An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res (2000) 2.36
Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. J Cell Sci (2002) 2.32
Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice. Hepatology (1998) 2.04
Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol (2002) 1.69
Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab Invest (1996) 1.65
Soluble mediators of inflammation during tumor development. Adv Cancer Res (2005) 1.24
Characterization of cell lines established from human hepatocellular carcinoma. Int J Cancer (1995) 1.24
Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40. J Immunol (2005) 1.18
Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules. Cancer Immunol Immunother (2005) 1.17
Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. J Hepatol (1999) 1.10
CD63 as an activation-linked T cell costimulatory element. J Immunol (2004) 1.08
A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis (2005) 1.08
Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol (2003) 1.07
The role of immune cells in the tumor microenvironment. Cancer Treat Res (2006) 1.03
Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol (1997) 1.01
Genotype-phenotype relationships in hepatocellular tumors from mice and man. Hepatology (2005) 0.99
NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. J Hepatol (2006) 0.98
Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease. Am J Pathol (2004) 0.97
Enhancement of hepatitis C virus replication by Epstein-Barr virus-encoded nuclear antigen 1. EMBO J (1999) 0.96
Multiple chromosomal abnormalities in human liver (pre)neoplasia. J Hepatol (2004) 0.96
Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. J Med Virol (2005) 0.96
Promyelocytic HL60 cells express NADPH oxidase and are excellent targets in a rapid spectrophotometric microplate assay for extracellular superoxide. Toxicol Sci (2003) 0.95
Detection of Epstein-Barr virus DNA in hepatocellular carcinoma tissues from hepatitis C-positive patients. Scand J Gastroenterol (2000) 0.95
Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection. Cancer (1989) 0.94
Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas. Am J Surg Pathol (2006) 0.94
Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer (2002) 0.92
The plasticity of p19 ARF null hepatic stellate cells and the dynamics of activation. Biochim Biophys Acta (2005) 0.92
Inflammation, damage repair, immune cells, and liver fibrosis: specific or nonspecific, this is the question. Gastroenterology (2004) 0.90
Peroxisome proliferators do not increase DNA synthesis in purified rat hepatocytes. Carcinogenesis (2001) 0.88
Establishment of cell lines from a primary hepatocellular carcinoma and its metastatis. Cancer Genet Cytogenet (2004) 0.87
Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis. Carcinogenesis (2005) 0.87
Initiated rat hepatocytes in primary culture: a novel tool to study alterations in growth control during the first stage of carcinogenesis. Carcinogenesis (2000) 0.85
Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3. Pancreas (1990) 0.82
Expression and cellular localization of the urokinase-type plasminogen activator and its receptor in human hepatocellular carcinoma. J Pathol (2000) 0.80
Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Hum Exp Toxicol (1996) 0.77
The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene (2007) 4.90
Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat Genet (1998) 4.01
In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology (1995) 3.67
Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet (1997) 3.03
Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function. J Invest Dermatol (1989) 2.63
Electrical transmission at the nexus between smooth muscle cells. J Gen Physiol (1968) 2.54
Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc Natl Acad Sci U S A (1992) 2.54
Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain (1981) 2.40
Primary interferon resistance and treatment response in chronic hepatitis C infection: a pilot study. Lancet (2001) 2.40
A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations. Am J Transplant (2013) 2.39
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J (2001) 2.32
Self-recognition of CD1 by gamma/delta T cells: implications for innate immunity. J Exp Med (2000) 2.30
CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor. J Immunol (1993) 2.19
Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum Mol Genet (1999) 2.15
Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat Embryol (Berl) (1999) 2.12
The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet (2000) 2.08
Molecular characterization and functional analysis of the leukocyte surface protein CD31. J Immunol (1990) 2.07
Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol (1983) 2.03
Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (1990) 2.00
Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol (1996) 1.99
Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann N Y Acad Sci (2000) 1.93
A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc Natl Acad Sci U S A (2005) 1.93
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases. Hepatology (2001) 1.92
Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Leukemia (2009) 1.92
Positional cloning of the gene for X-linked retinitis pigmentosa 3: homology with the guanine-nucleotide-exchange factor RCC1. Hum Mol Genet (1996) 1.90
Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci (1992) 1.90
High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci U S A (1992) 1.90
A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). J Immunol (1984) 1.90
Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med (1995) 1.89
Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci U S A (1992) 1.87
TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J Immunol (1996) 1.87
Predicting and evaluating response to omalizumab in patients with severe allergic asthma. Respir Med (2007) 1.86
Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics (2001) 1.86
Functions of c-Jun in liver and heart development. J Cell Biol (1999) 1.85
The retinitis pigmentosa GTPase regulator (RPGR) interacts with novel transport-like proteins in the outer segments of rod photoreceptors. Hum Mol Genet (2000) 1.84
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75
Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol (1998) 1.73
Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci U S A (1992) 1.72
Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia (2006) 1.70
Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays. FASEB J (2001) 1.70
T cell stimulation via the erythrocyte receptor. Synergism between monoclonal antibodies and phorbol myristate acetate without changes of free cytoplasmic Ca++ levels. J Exp Med (1986) 1.68
Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group. Br J Dermatol (2006) 1.67
Lessons from keratin 18 knockout mice: formation of novel keratin filaments, secondary loss of keratin 7 and accumulation of liver-specific keratin 8-positive aggregates. J Cell Biol (1998) 1.65
A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene (2006) 1.62
KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab. Br J Surg (2012) 1.60
MEDLINE demand profiles: an analysis of requests for clinical and research information. Bull Med Libr Assoc (1977) 1.59
Novel mutations in the folliculin gene associated with spontaneous pneumothorax. Eur Respir J (2008) 1.57
A novel insulin formulation with a more rapid onset of action. Diabetologia (2008) 1.57
Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol (1996) 1.56
Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J Exp Med (1998) 1.54
'Blind' antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Ann Oncol (2006) 1.54
RPGR transcription studies in mouse and human tissues reveal a retina-specific isoform that is disrupted in a patient with X-linked retinitis pigmentosa. Hum Mol Genet (1999) 1.53
Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells. Blood (1996) 1.52
Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit Rev Toxicol (1996) 1.51
CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol (1990) 1.51
Characterization of a second highly conserved B-type lamin present in cells previously thought to contain only a single B-type lamin. Chromosoma (1990) 1.50
Association between Helicobacter pylori infection and pancreatic cancer. Oncology (1998) 1.49
Co-expression of cytokeratin and vimentin filaments in rete testis and epididymis. An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol (1991) 1.49
Corrective reactions to stumbling in man: neuronal co-ordination of bilateral leg muscle activity during gait. J Physiol (1984) 1.48
PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene (2006) 1.48
Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res (1998) 1.47
Visual influence on human locomotion. Modulation to changes in optic flow. Exp Brain Res (1997) 1.47
Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Clin Exp Allergy (2014) 1.45
Complete remission of metastasised clear cell sarcoma of tendons and aponeuroses. Eur J Cancer (1991) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene (2009) 1.43
Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ (2003) 1.41
Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus. Gastroenterology (1998) 1.41
A comparative study of unsedated transnasal esophagogastroduodenoscopy and conventional EGD. Gastrointest Endosc (1996) 1.40
A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther (2007) 1.40
Antigenic analysis of human haemopoietic progenitor cells expressing the growth factor receptor c-kit. Br J Haematol (1992) 1.40
Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci (2009) 1.39
1995 directory for the human leukocyte clusters of differentiation. Transfusion (1996) 1.39
Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroenterol (1997) 1.37
Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells. Int J Cancer (1999) 1.36
Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant (2010) 1.36
Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug Chem (1993) 1.35
Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood (1989) 1.33
Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey. Am J Trop Med Hyg (2001) 1.33
Retinal vasculature changes in Norrie disease mice. Invest Ophthalmol Vis Sci (1998) 1.33
MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol (1997) 1.32
Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology (2001) 1.32
IgM and IgG but not cytokine secretion is restricted to the CD27+ B lymphocyte subset. J Immunol (1992) 1.32
Liver carcinoma prevention among Asian Pacific Islanders. Getting hepatitis B shots into arms. Cancer (2001) 1.31
Interlimb coordination of posture in patients with spastic paresis. Impaired function of spinal reflexes. Brain (1984) 1.31
Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res (2001) 1.31
Signal transduction in lymphocytic and myeloid cells via CD24, a new member of phosphoinositol-anchored membrane molecules. J Immunol (1990) 1.31
Corrective reactions to stumbling in man: functional significance of spinal and transcortical reflexes. Neurosci Lett (1984) 1.30
Normal and impaired regulation of muscle stiffness in gait: a new hypothesis about muscle hypertonia. Exp Neurol (1983) 1.30
Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol (1974) 1.29
Ligation of E-cadherin on in vitro-generated immature Langerhans-type dendritic cells inhibits their maturation. Blood (2000) 1.28
IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol (1989) 1.28
Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology (1997) 1.27
[Biobanking and Biomolecular Resources Research Infrastructure (BBMRI). Implications for pathology]. Pathologe (2008) 1.26
Interleukin 3 activates human blood basophils via high-affinity binding sites. Proc Natl Acad Sci U S A (1989) 1.26
Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut (2005) 1.25